Ziding D. Feng

Affiliations: 
University of Washington, Seattle, Seattle, WA 
Area:
Biostatistics Biology
Google:
"Ziding Feng"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tosoian JJ, Zhang Y, Xiao L, et al. (2024) Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. Jama Oncology
Liu S, Hawley SJ, Kunder CA, et al. (2024) High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker. Scientific Reports. 14: 486
Ruder S, Gao Y, Ding Y, et al. (2022) Development and Validation of a Quantitative Reactive Stroma Biomarker (qRS) for Prostate Cancer Prognosis. Human Pathology
Singal AG, Lok AS, Feng Z, et al. (2020) Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda Clinical Gastroenterology and Hepatology
Dai JY, Wang X, Wang B, et al. (2020) DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs. Plos Genetics. 16: e1008667
Wang X, Grasso CS, Jordahl KM, et al. (2020) Copy number alterations are associated with metastatic-lethal progression in prostate cancer. Prostate Cancer and Prostatic Diseases
Schwartz NR, Matrisian LM, Shrader E, et al. (2020) The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes. Journal of Clinical Oncology. 38: 7017-7017
Wang L, Huang Y, Feng Z. (2019) Strategies for validating biomarkers using data from a reference set. Biostatistics (Oxford, England)
Cheng A, Zhao S, FitzGerald LM, et al. (2019) A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies. The Prostate
Borges KA, Dai J, Parikh ND, et al. (2018) Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's early Detection Research Network. Contemporary Clinical Trials
See more...